Cost Effectiveness of ACEIs/ARBs versus Amlodipine Monotherapies: A Single-Center Retrospective Chart Review

Cost Effectiveness of ACEIs/ARBs versus Amlodipine Monotherapies: A Single-Center Retrospective Chart Review

The aim of this retrospective chart review study was to examine the cost effectiveness of angiotensin-converting enzyme inhibitors (ACEIs); angiotensin receptor blockers (ARBs); and dihydropyridine calcium channel blockers (CCBs) such as amlodipine, monotherapies in the management of essential hyper...

Full description

Bibliographic Details
Main Authors:	Yazed AlRuthia, Fahad Alotaibi, Amr Jamal, Ibrahim Sales, Monira Alwhaibi, Nawaf Alqahtani, Sina M. AlNajrany, Khalid Almalki, Abdulaziz Alsaigh, Wael Mansy
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	Healthcare
Subjects:	hypertension angiotensin-converting enzyme inhibitors angiotensin receptor antagonists calcium channel blockers cost effectiveness Saudi Arabia
Online Access:	https://www.mdpi.com/2227-9032/9/7/798

Similar Items

Effect of ACEi and ARBs vs Non ACEi/ARBs in Hypertension with Respect to Renal Outcomes in COVID-19 Infection: A Retrospective Cohort Study
by: S Ravitej, et al.
Published: (2022-11-01)

Final results of BIRCOV trial (ARB, ACEI, DRi in COVID-19)
by: D.D. Ivanov, et al.
Published: (2021-09-01)

Association of ACEi/ARB Use and Clinical Outcomes of COVID-19 Patients With Hypertension
by: Jing Ma, et al.
Published: (2021-05-01)

ARNI versus ACEI/ARB in Reducing Cardiovascular Outcomes after Myocardial Infarction
by: Jianqing She, et al.
Published: (2021-12-01)

Effects of ACEI/ARB or CCB use on atrial fibrillation in hypertensive patients following permanent pacemaker implantation
by: Zhijie Liu, et al.
Published: (2023-06-01)

S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial
by: Sang-Ho Jo, et al.
Published: (2018-06-01)

Severity of COVID-19 infection in ACEI/ARB users in specialty hospitals: A retrospective cohort study
by: Ahmed A. Alrashed, et al.
Published: (2021-06-01)

Group-Based Trajectory Modeling to Identify Patterns of Adherence and Its Predictors Among Older Adults on Angiotensin-Converting Enzyme Inhibitors (ACEIs)/Angiotensin Receptor Blockers (ARBs)
by: Paranjpe R, et al.
Published: (2020-10-01)

Patient-Reported Barriers to Adherence Among ACEI/ARB Users from a Motivational Interviewing Telephonic Intervention
by: Majd Z, et al.
Published: (2022-10-01)

Effect of sacubitril/valsartan and ACEI/ARB on glycaemia and the development of diabetes: a systematic review and meta-analysis of randomised controlled trials
by: Ruxin Wang, et al.
Published: (2022-12-01)

Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study
by: Ihm SH, et al.
Published: (2016-11-01)

The Effect of Pentoxifylline in Reducing Proteinuria in Patients with Diabetic Nephropathy Treated with ACEI or ARB
by: Iranparvar, et al.
Published: (2017-10-01)

Mortality, Severity, and Hospital Admission among COVID-19 Patients with ACEI/ARB Use: A Meta-Analysis Stratifying Countries Based on Response to the First Wave of the Pandemic
by: Ahmad A. Alamer, et al.
Published: (2021-01-01)

Developing a multi-center clinical data mart of ACEI and ARB for real-world evidence (RWE)
by: Hun-Sung Kim, et al.
Published: (2018-12-01)

The efficacy and safety of sacubitril/valsartan compared with ACEI/ARB in the treatment of heart failure following acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials
by: Jinquan Gao, et al.
Published: (2023-08-01)

Long-term oral ACEI/ARB therapy is associated with disease severity in elderly COVID-19 omicron BA.2 patients with hypertension
by: Zhe Zhang, et al.
Published: (2023-12-01)

Effectiveness and Safety of Fixed-dose Combination of Perindopril/Amlodipine/Indapamide, and Telmisartan/Amlodipine/Chlorthalidone in Grade 2 Hypertensive Patients at High Cardiovascular Risk: A Real-world Observational Study
by: Shambo Samrat Samajdar, et al.
Published: (2023-01-01)

Real-world use of ACEI/ARB in diabetic hypertensive patients before the initial diagnosis of obstructive coronary artery disease: patient characteristics and long-term follow-up outcome
by: Yue Zhang, et al.
Published: (2020-04-01)

ARB Compared with non-ARB in Preventing Cardiac Events in High Risk Hypertensive Patients: An Evidence Based Case Report
by: Alvin Nursalim, et al.
Published: (2013-06-01)

Efficacy and safety of valsartan/amlodipine single-pill combination in patients with essential hypertension (PEAK LOW)
by: Pınar Kızılırmak, et al.
Published: (2014-06-01)

Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors?
by: Elena Raccuglia, et al.
Published: (2009-11-01)

Perspectives of using angiotensin receptor antagonists
by: V V Fomin
Published: (2009-06-01)

Prospective direct comparison of antihypertensive effect and safety between high-dose amlodipine or indapamide in hypertensive patients uncontrolled by standard doses of angiotensin receptor blockers and amlodipine
by: Keisuke Okamura, et al.
Published: (2018-02-01)

The evolution of systolic blood pressure as a strong predictor of cardiovascular risk and the effectiveness of fixed-dose ARB/CCB combinations in lowering levels of this preferential target
by: Jean-Jacques Mourad
Published: (2008-12-01)

ANALYSIS OF CHANGE IN NT-proBNP AFTER ANGIOTENSIN RECEPTOR BLOCKER (ARB) THERAPY IN PATIENT WITH HEART FAILURE
by: Intan Kusuma Dewi, et al.
Published: (2017-08-01)

The complete reversal effect following angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and beta-blockers after the primary diagnosis of dilated cardiomyopathy
by: Tao Liu, et al.
Published: (2023-01-01)

Vasorelaxant Effect of a Newly Synthesized Dihydropyridine Ethyl Ester (DHPEE) on Rat Thoracic Aorta: Dual Mechanism of Action
by: Hossein Babaei, et al.
Published: (2011-06-01)

Disease modifying effects of simvastatin &/or telmisartan on pulmonary function in patients with mild to moderate chronic obstructive pulmonary disease(COPD)
by: Ali M. Hadi, et al.
Published: (2012-01-01)

Amlodipine and valsartan improving effect on the survival rate and deleterious pathological changes in streptozotocin-induced diabetic rats treated with metformin
by: Israel Olapeju Bolanle, et al.
Published: (2019-04-01)

Molecular targeting therapy with angiotensin II receptor blocker for prostatic cancer
by: Hiroji Uemura, et al.
Published: (2011-12-01)

Molecular targeting therapy with angiotensin II receptor blocker for prostatic cancer
by: Hiroji Uemura, et al.
Published: (2011-12-01)

Olmesartan in Management of Proteinuria
by: Satyanarayan Routray, et al.
Published: (2018-02-01)

Angiotensins and rheumatoid arthritis
by: N. M. Savushkina, et al.
Published: (2019-01-01)

Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ
by: Duprez D, et al.
Published: (2011-11-01)

Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study
by: Jenny I. Shen, et al.
Published: (2017-06-01)

Concomitant use of renin-angiotensin-aldosterone system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional retrospective study
by: Melissa Y. Y. Moey, et al.
Published: (2019-07-01)

Effect of angiotensin-converting enzyme inhibitors versus that of angiotensin receptor blockers on survival in patients undergoing hemodialysis: a nationwide observational cohort study
by: Seok Hui Kang, et al.
Published: (2024-12-01)

ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2017-07-01)

The problem of determining the efficiency of treatmentin the era of evidence-based medicine: international and domestic experience
by: S R Gilyarevsky
Published: (2014-06-01)

Clinical Impact of ACE-I/ARB for Conservatively Treated Patients with Moderate to Severe Mitral Regurgitation: A Single Center Observational Study
by: Robert Uzel, et al.
Published: (2023-04-01)